New CD40 agonist antibody engineered for enhanced effectiveness.
Direct injection into tumors leads to systemic cancer reduction.
Early trials indicate significant potential for broader applications.
New CD40 agonist antibody engineered for enhanced effectiveness.
Direct injection into tumors leads to systemic cancer reduction.
Early trials indicate significant potential for broader applications.